European Journal of Cardiovascular Medicine

Introduction: Gestational diabetes affects a significant proportion of pregnant women and can have adverse health effects for both the mother and the baby. Monitoring blood glucose levels and lipid profiles is crucial in managing this condition. This comparative study examines how glycosylated hemoglobin (HbA1c) and lipid profile parameters change in women with gestational diabetes compared to normoglycemic pregnant women, with the goal of improving diagnostic and management strategies for this condition. The aim of this study was to determine that HbA1c is an independent marker of dyslipidaemia among GDM cases and emphasize the link between the aforementioned parameters among pregnant women in Bihar. Materials and Methods: In this comparative study, we included fifty patients who were diagnosed with gestational diabetes during pregnancy. All of the antenatal women were in their third trimester. We also included another fifty pregnant women as controls, who did not have gestational diabetes or any other pregnancy complications in their third trimester. Both the cases and controls were randomly selected from the age group of 20 to 45 years. In this study, we measured the serum lipid profile parameters, oral glucose tolerance test blood glucose levels, and glycosylated haemoglobin levels in patients with gestational diabetes, and compared them with those of healthy pregnant women. Results: In this study, 50 pregnant women with GDM had a mean age of 31.2 years, while 50 pregnant women in the healthy control group had a mean age of 29.3 years. In the present study, serum triglycerides were observed at 193.12±10.12 mg/dL in GDM cases and 150.76±8.54 mg/dL in the control group, while serum total cholesterol was observed at 211.43±14.34 mg/dL in GDM cases and 168.83±18.19 mg/dL in the control group. The levels of serum triglycerides and serum cholesterol in GDM cases were statistically significantly higher as compared to the controls. The serum HDL cholesterol was observed at 57.98±5.78 mg/dL in GDM cases and 55.12±6.67 mg/dL in the control group, while serum LDL cholesterol was observed at 92.13±13.45 mg/dL in GDM cases and 82.03±10.16 mg/dL in the control group. There was no statistically significant difference in their HDL and LDL Cholesterol in the cases and control group. The fasting blood glucose was recorded at 116±9.65 mg/dL in GDM cases and 89±5.89 mg/dL in the control group, the blood glucose level after 1 hour of 75grams oral glucose administration in oral glucose tolerance test was observed at 198.13±12.74 mg/dL in GDM cases and 158.33±9.34 mg/dL in the control group while blood glucose level after 2 hours was observed at 174.38±11.48 mg/dL in GDM cases and 140.11±7.87 mg/dL in the control group. The differences between cases and controls were statistically significant. The mean value of the HbA1c of cases and control groups was 8.15±1.12 mg/dL and 6.02±0.18 mg/dL respectively. This difference between healthy pregnant women and women with GDM was statistically significant. Conclusion: The study's findings have conclusively demonstrated that triglyceride, high-density lipoprotein, glycated haemoglobin, and glucose levels in the blood all play a significant role in the development of dyslipidemia in gestational diabetes mellitus (GDM). Although it is well known that lipid parameters increase during a healthy pregnancy, the way they increase in GDM is different.